LABS MediPharm Labs Corp.

0.0384USD0.0550 CAD · TSX-8.33%Mkt Cap: 16.42M USDP/E: —

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Cana…

Institutional holders2 on file

Key Statistics

Company
Market Cap16.42M USD
Enterprise Value9.59M USD
Revenue (TTM)29.23M USD
Gross Profit9.76M USD
Net Income (TTM)-5.78M USD
Revenue/Share0.07 USD
Last Price0.0384 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees127
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58504D1006
Valuation
P/E (Trailing)—
P/E (Forward)-5.50
PEG—
EV/EBITDA-42.20
EV/Revenue0.33
P/S0.56
P/B0.66
EPS (TTM)-0.0070 USD
EPS (Forward)-0.0070 USD
52W Range
0.03840% of range0.0699
52W High0.0699 USD
52W Low0.0384 USD
Profitability
Gross Margin30.95%
Oper. Margin-4.30%
EBITDA Margin-0.78%
Profit Margin-18.32%
ROE-23.08%
ROA-18.07%
ROIC-26.35%
ROCE-23.48%
Growth
Revenue Growth3.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.85M USD
CapEx (TTM)69.90K USD
FCF Margin2.11%
FCF Yield3.75%
Net Debt-6.84M USD
Net Debt/EBITDA30.10
Net Debt/FCF-11.10
Balance Sheet
Debt/Equity0.01
Current Ratio2.66
Quick Ratio1.78
Book Value/Sh0.06 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.427.18M
Float390.00M
Insiders11.64%
Institutions0.00%
Short Interest
Short Ratio3.2d
Short % Out.0.08%
Shares Short344.99K
Short (prev mo.)223.40K
Technical
SMA 500.0470 (-18.3%)
SMA 2000.0501 (-23.2%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)164.07K
Avg Vol (10d)238.79K
Technical Indicators
RSI (14)36.9
MACD-0.0016
MACD Signal-0.0014
MACD Hist.-0.0003
BB Upper0.0493 USD
BB Middle0.0440 USD
BB Lower0.0388 USD
BB Width23.93%
ATR (14)0.0033 USD
Vol Ratio (20d)3.63x

About MediPharm Labs (TSE: LABS)

›

MediPharm Labs (TSE: LABS) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 127 employees.

The shares were at 0.0550 CAD on 19 November 2026, down 21.4% over 52 weeks. Its 52-week range is 0.0550 CAD to 0.1000 CAD, and it trades at the bottom of that range.

Its market capitalisation is 23.49M CAD.

MediPharm Labs reports return on equity of -23.1%, an operating margin of -4.3% and revenue up 3.1% year over year.

It holds more cash than debt, a net cash position of 9.78M CAD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 29 March 2027.